Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_provenance.
• NP318884.RAo5BHnzHG4cWN7OJM6rfm_6Ry9hGaDZd6EL0ZvbY-jzM130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318884.RAo5BHnzHG4cWN7OJM6rfm_6Ry9hGaDZd6EL0ZvbY-jzM130_provenance.
• NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_provenance.
• NP534139.RAtA6LuLgsoX6HGqX4MT29KN8yEE0tVUGddkuRUGjK758130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534139.RAtA6LuLgsoX6HGqX4MT29KN8yEE0tVUGddkuRUGjK758130_provenance.
• NP488551.RAJZ8gEuTz_bxjhfFiB4KUom7gBY-EhDzgpSNfG2YhAa4130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP488551.RAJZ8gEuTz_bxjhfFiB4KUom7gBY-EhDzgpSNfG2YhAa4130_provenance.
• NP1088721.RAecOQWBf3uaiYe3mRJVAygjQ_XbAAq-MEDvTY5b3xdVk130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1088721.RAecOQWBf3uaiYe3mRJVAygjQ_XbAAq-MEDvTY5b3xdVk130_provenance.
• NP1088722.RAVmMDqVR1qKcBRcoNnClgzTdKsCKM7pzAyCGed5NY3JA130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1088722.RAVmMDqVR1qKcBRcoNnClgzTdKsCKM7pzAyCGed5NY3JA130_provenance.
• NP1088730.RAUVavbxMVZFmjuHnybjvluOTE4djjksoOvAsTwCNRUTw130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1088730.RAUVavbxMVZFmjuHnybjvluOTE4djjksoOvAsTwCNRUTw130_provenance.
• NP1088731.RAXdnjFhxG3_8Cwoc1Bzll921lbXXjGrpXNcgA2HmRO_8130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1088731.RAXdnjFhxG3_8Cwoc1Bzll921lbXXjGrpXNcgA2HmRO_8130_provenance.
• NP1088724.RAqp1EsuYqWQO1kOccM4yLtpIcQKkrvsSXovTIiIMk4hc130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1088724.RAqp1EsuYqWQO1kOccM4yLtpIcQKkrvsSXovTIiIMk4hc130_provenance.
• NP1088727.RAMQitrTUXwCaKog98qQOgFur16QkyiFkBJy8tuECjj3k130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1088727.RAMQitrTUXwCaKog98qQOgFur16QkyiFkBJy8tuECjj3k130_provenance.
• NP1088720.RA3pSO6-nwam3gyFhRvgQ-iUrUlnIBA8V2EjvSqdXNopE130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1088720.RA3pSO6-nwam3gyFhRvgQ-iUrUlnIBA8V2EjvSqdXNopE130_provenance.
• NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_provenance.
• NP1088726.RA50-RptY3-dnxOh3SY3WE2O0oXkFEtoxkFRpJlvyM2Lw130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1088726.RA50-RptY3-dnxOh3SY3WE2O0oXkFEtoxkFRpJlvyM2Lw130_provenance.
• NP1088729.RAwgcyG8ZC9COLXxsUrE-BG_SQnrjHKYYS4AsH0xcYQFs130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1088729.RAwgcyG8ZC9COLXxsUrE-BG_SQnrjHKYYS4AsH0xcYQFs130_provenance.